Search Results

0 results for 'Takeda'

You can use to get even better search results
Laufer v. 7 Hills Hotel LLC
Publication Date: 2022-11-16
Practice Area: Civil Procedure
Industry: Hospitality and Lodging
Court: U.S. District Court for the Northern District of New York, U.S. - NDNY
Judge: Chief Judge Brenda K. Sannes
Attorneys:
For plaintiff: For Plaintiff: Tristan Wade Gillespie, Thomas B. Bacon, P.A., Johns Creek, GA.
For defendant: For Defendant: Justin R. Meyer, Stafford, Owens, Murnane, Kelleher, Miller, Meyer & Zedick, PLLC, One Cumberland Avenue, Plattsburgh, NY.
Case number: 8:22-CV-53

'Zagano' Factors Favor ADA Suit's Voluntary Dismissal; Vexatious Litigant Status Is Denied

Takeda Pharm. Co. Ltd. v. Norwich Pharm, Inc.
Publication Date: 2022-10-21
Practice Area: Intellectual Property
Industry:
Court: U.S. District Court for New Jersey
Judge: District Judge Chesler
Attorneys:
For plaintiff:
For defendant:
Case number: 20-8966 (SRC)

Plaintiff moved to exclude certain opinions of defendant's expert and for summary judgment that seven claims were infringed and not invalid in plaintiff's infringement action.

Takeda Pharm. Co. Ltd. v. Norwich Pharm., Inc.
Publication Date: 2022-07-27
Practice Area: Intellectual Property
Industry:
Court: U.S. District Court for New Jersey
Judge: District Judge Chesler
Attorneys:
For plaintiff:
For defendant:
Case number: 20-8966 (SRC)

Plaintiffs moved to extend the 30-month stay of FDA approval, while defendant appealed from the magistrate judge's vacate order.

Takeda Pharm. Co. Ltd. v. Zydus Pharm., Inc.
Publication Date: 2022-05-31
Practice Area: Intellectual Property
Industry:
Court: U.S. District Court for New Jersey
Judge: District Judge Wolfson
Attorneys:
For plaintiff:
For defendant:
Case number: 18-11792 (FLW)

Defendants moved for attorneys' fees pursuant to 35 U.S.C.

May 05, 2022 | New York Law Journal

Rule 9(b) Pleading Requirements Under the False Claims Act

The governing law in the U.S. Court of Appeals for the Second Circuit, including the need to plead representative examples of fraudulent claims, derives from the Second Circuit's decision in 'U.S. ex rel. Chorches v. American Medical Response'.
10 minute read
Law Journal Press | Digital Book District of Columbia Legal Malpractice Law 2024 Authors: Shari L. Klevens, Alanna G. Clair View this Book

View more book results for the query "Takeda"

Takeda Pharm. Co. Ltd. v. Norwich Pharm., Inc.
Publication Date: 2022-05-03
Practice Area: Intellectual Property
Industry:
Court: U.S. District Court for New Jersey
Judge: District Judge Chesler
Attorneys:
For plaintiff:
For defendant:
Case number: 20-8966 (SRC)

The parties sought claim construction on two disputed terms.

Value Drug Co. v. Takeda Pharm., U.S.A., Inc.
Publication Date: 2022-04-18
Practice Area: Antitrust
Industry: Distribution and Wholesale | Pharmaceuticals
Court: U.S. District Court for Pennsylvania - Eastern
Judge: District Judge Kearney
Attorneys:
For plaintiff:
For defendant:
Case number: 22-0419

Defendants moved to dismiss plaintiff's antitrust action alleging conspiracy to restrain trade and court found plaintiff plausibly pled a single horizontal conspiracy among defendant and three generics by pleading consciously parallel conduct and plausible motive for each conspirator, the conspirators acted against their unilateral interests and other facts that supported an inference of conspiracy but plaintiff did not plead a plausible separate bilateral conspiracy theory to restrict output. Motion granted in part and denied in part

April 14, 2022 | New York Law Journal

See Who Passed the February 2022 New York Bar Exam

The New York State Board of Law Examiners examined a total of 3,068 candidates, 1,378 of whom passed for an overall passing rate of 45%.
20 minute read
Takeda Pharm. Co. Ltd. v. Norwich Pharm. Inc.
Publication Date: 2022-03-18
Practice Area: Intellectual Property
Industry:
Court: U.S. District Court for New Jersey
Judge: District Judge Chesler
Attorneys:
For plaintiff:
For defendant:
Case number: 20-8966 (SRC)

The parties sought claim construction of terms in various patents in dispute.

March 02, 2022 | The Recorder

Nixon Peabody Grows Revenue 7.8% in New Chair's First Year

Nixon Peabody Chairman and CEO Stephen Zubiago is eyeing further growth on the West Coast, particularly in Los Angeles and San Francisco.
5 minute read

TRENDING STORIES

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now